Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities HALO - Halozyme Therapeutics, Inc.
-263 M
LAST VALUE
26.55%
2 YEAR CAGR
-116.30%
5 YEAR CAGR
-23.07%
10 YEAR CAGR